Catalio Capital Management
New York Β· 2 people tracked
Investment thesis
Catalio is a software platform that uses AI to automatically extract and document business logic from legacy and modern systems, creating living specifications that stay current as software evolves.
Source: firm website, verified Aug 6, 2026.
Team Β· 2 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech Γ1
HQs:United StatesΓ1
Investments Β· 1 tracked
founders shown can be your intro pathBiotechBoston, US
John W. Hoppin(Executive Officer, Director)John Babich(Director)Marc Becker(Executive Officer)Scott MacDonald(Executive Officer)William Cowan(Director)Susan Whoriskey(Director)
Frequently asked questions
- What sectors does Catalio Capital Management focus on?
- Catalio Capital Management focuses on Developer Tools, Enterprise Software.
- Where is Catalio Capital Management located?
- Catalio Capital Management is headquartered in New York, US.
Images
Co-investors Β· 12
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Dimension is a multistage investment firm that partners with companies working at the intersection of science and compute.
Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Vivo Capital is a global healthcare-focused investment firm operating a multi-strategy platform spanning venture capital, private equity, and public equity. It aims to expand healthcare access and drive innovation through its 'Ecosystem Strategy.'
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
Catalio is a New York-based investment firm focused on innovative healthcare, investing across the full lifecycle through private, public, and credit markets.
Inveready is a Spanish alternative investment firm founded in 2008, offering investment solutions and wealth management services across the small and mid-market segment in Spain.
Firms observed investing alongside Catalio Capital Management, from public investor directories.









